ACCESSION: MSBNK-SMB_Measured-HSA032P0259002
RECORD_TITLE: Characterized; methyl (2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoate; LC-ESI-QTOF; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 17
COMMENT: RAW_SPEC {'RA1-pos_2243': {'bp': 9273.0, 'sum': 12588.0}, 'RA20-pos_2108': {'bp': 3270.0, 'sum': 4136.0}, 'RA10-pos_2058': {'bp': 2103.0, 'sum': 3488.0}, 'RA23-pos_1985': {'bp': 2077.0, 'sum': 2971.0}, 'RA2-pos_2189': {'bp': 1715.0, 'sum': 2937.0}, 'HC21-pos_1953': {'bp': 1430.0, 'sum': 2450.0}, 'HC17-pos_1973': {'bp': 1209.0, 'sum': 2264.0}, 'RA13-pos_1971': {'bp': 1151.0, 'sum': 2017.0}, 'RA3-pos_2046': {'bp': 1139.0, 'sum': 1700.0}, 'RA12-pos_2216': {'bp': 1108.0, 'sum': 1669.0}, 'HC5-pos_2126': {'bp': 991.0, 'sum': 1501.0}, 'QC4-pos_1989': {'bp': 946.0, 'sum': 1660.0}, 'QC8-pos_1928': {'bp': 755.0, 'sum': 1214.0}, 'HC16-pos_2271': {'bp': 634.0, 'sum': 889.0}, 'HC23-pos_2013': {'bp': 627.0, 'sum': 831.0}, 'HC22-pos_1919': {'bp': 516.0, 'sum': 1077.0}, 'QC5-pos_1960': {'bp': 491.0, 'sum': 593.0}}
COMMENT: RETENTION_TIME_STDEV 0.005
COMMENT: PRECURSOR_M/Z_RAW 259.200393
COMMENT: PRECURSOR_M/Z_STDEV 0.000785
COMMENT: PRECURSOR_IN_MS1 mz 259.201108; int 155.094; delta(ppm) 12.652169
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 13.509; C12H27N4P; [M+H]+; delta(ppm) -13.509230
COMMENT: PROPOSED_MF SevenGoldenRules 1.933; C13H26N2O3; [M+H]+; delta(ppm) -1.932656
COMMENT: PROPOSED_MF MS-FINDER 4.375; C13H26N2O3; [M+H]+; delta(ppm) -1.925691
COMMENT: PROPOSED_MF MS-FINDER 2.758; C9H22N8O; [M+H]+; delta(ppm) 8.434391
COMMENT: PROPOSED_MF MS-FINDER 2.472; C9H30N4S2; [M+H]+; delta(ppm) 10.241502
COMMENT: PROPOSED_MF SIRIUS5_Sirius 13.392; C13H26N2O3; [M+H]+; delta(ppm) -1.925691
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C13H26N2O3; [M+H]+; delta(ppm) -1.925691
COMMENT: PROPOSED_MF SIRIUS6_Sirius 20.976; C13H26N2O3; [M+H]+; delta(ppm) -1.925691
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.225; C9H22N8O; [M+H]+; delta(ppm) 8.434391
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.612; C11H24N5O2; [M+H]+; delta(ppm) 3.254323
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C13H26N2O3; [M+H]+; delta(ppm) -1.925691
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.885; CMQIGLGSRAQZAD-QWRGUYRKSA-N; [M+H]+; CCCCC(C(=O)NC(CCCC)C(=O)OC)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.737; AJMOLNFDYWTVQW-QWRGUYRKSA-N; [M+H]+; CC(C)CC(C(=O)NC(CC(C)C)C(=O)OC)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.527; AXIXBULJQSPZTL-UHFFFAOYSA-N; [M+H]+; O=C(NCCC(C)C)NC(C(=O)OC)C(C)CC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.244; LKAKFPMASSTTNS-UHFFFAOYSA-N; [M+H]+; OCC1OC(CN(C)C)C(N2CCCCC2)C1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.168; SYZRWJMIOVIOAQ-UHFFFAOYSA-N; [M+H]+; OCC1OC(CNC2CCCCC2)C(NC)C1O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.334; LKAKFPMASSTTNS-UHFFFAOYSA-N; [M+H]+; 5-[(dimethylamino)methyl]-2-(hydroxymethyl)-4-(piperidin-1-yl)oxolan-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.268; WTSZPGPMXVFMCG-UHFFFAOYNA-N; [M+H]+; 4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.268; ADEABMIOOCQJNK-UHFFFAOYSA-N; [M+H]+; N-{[4-(dimethylamino)-3-hydroxyoxolan-2-yl]methyl}-3,3-dimethylbutanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.268; MINKIWKBNNDDEK-UHFFFAOYSA-N; [M+H]+; 2-(hydroxymethyl)-5-{[(propan-2-yl)amino]methyl}-4-(pyrrolidin-1-yl)oxolan-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.254; AJMOLNFDYWTVQW-QWRGUYRKSA-N; [M+H]+; methyl (2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.249; CMQIGLGSRAQZAD-QWRGUYRKSA-N; [M+H]+; methyl (2S)-2-[[(2S)-2-aminohexanoyl]amino]hexanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.210; VVTOFDPELUVSDP-UHFFFAOYSA-N; [M+H]+; 4-(hydroxymethyl)-4-{[(1-methylpiperidin-4-yl)amino]methyl}cyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.209; SYZRWJMIOVIOAQ-UHFFFAOYSA-N; [M+H]+; 5-[(cyclohexylamino)methyl]-2-(hydroxymethyl)-4-(methylamino)oxolan-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.192; MPCFXRWRKGJJPM-UHFFFAOYSA-N; [M+H]+; 3-(methoxymethyl)-5-[(1-methylpiperidin-4-yl)amino]cyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.165; AXIXBULJQSPZTL-UHFFFAOYSA-N; [M+H]+; methyl 3-methyl-2-{[(3-methylbutyl)carbamoyl]amino}pentanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.679; BCPWSYQGYBTINM-PVAICXQDNA-N; [M+H]+; UNPD118363
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; AXIXBULJQSPZTL-UHFFFAOYSA-N; [M+H]+; methyl 3-methyl-2-{[(3-methylbutyl)carbamoyl]amino}pentanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.991; LKAKFPMASSTTNS-UHFFFAOYSA-N; [M+H]+; 5-[(dimethylamino)methyl]-2-(hydroxymethyl)-4-(piperidin-1-yl)oxolan-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.885; ADEABMIOOCQJNK-UHFFFAOYSA-N; [M+H]+; N-{[4-(dimethylamino)-3-hydroxyoxolan-2-yl]methyl}-3,3-dimethylbutanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.868; MINKIWKBNNDDEK-UHFFFAOYSA-N; [M+H]+; 2-(hydroxymethyl)-5-{[(propan-2-yl)amino]methyl}-4-(pyrrolidin-1-yl)oxolan-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.846; WTSZPGPMXVFMCG-UHFFFAOYNA-N; [M+H]+; 4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.837; MPCFXRWRKGJJPM-UHFFFAOYSA-N; [M+H]+; 3-(methoxymethyl)-5-[(1-methylpiperidin-4-yl)amino]cyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.837; VVTOFDPELUVSDP-UHFFFAOYSA-N; [M+H]+; 4-(hydroxymethyl)-4-{[(1-methylpiperidin-4-yl)amino]methyl}cyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.742; SYZRWJMIOVIOAQ-UHFFFAOYSA-N; [M+H]+; 5-[(cyclohexylamino)methyl]-2-(hydroxymethyl)-4-(methylamino)oxolan-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.695; AJMOLNFDYWTVQW-QWRGUYRKSA-N; [M+H]+; methyl (2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.695; CMQIGLGSRAQZAD-QWRGUYRKSA-N; [M+H]+; methyl (2S)-2-[[(2S)-2-aminohexanoyl]amino]hexanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; BCPWSYQGYBTINM-PVAICXQDNA-N; [M+H]+; UNPD118363
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.657; AJMOLNFDYWTVQW-QWRGUYRKSA-N; [M+H]+; methyl (2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.467; WTSZPGPMXVFMCG-UHFFFAOYSA-N; [M+H]+; 4-[2-(2-morpholin-4-ylethoxy)propyl]morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; DZQUGCQCUZQUBW-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(3-piperidin-4-yloxypropyl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.476; RQSDNHZKVDCJBG-UHFFFAOYSA-N; [M+H]+; 6-(pentan-2-ylamino)-1,2,3,5,6,7,8,8a-octahydroindolizine-1,7,8-triol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.473; JWQAHJZHEXWYME-UHFFFAOYSA-N; [M+H]+; 3-[(pentan-2-ylamino)methyl]-2,3,5,6,7,8-hexahydro-1H-pyrrolizine-1,2,7-triol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.305; XWSTYTJQZWDBEA-UHFFFAOYSA-N; [M+H]+; N,N-diethyl-4-hydroxy-5-morpholin-4-ylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.176; JDQHOQBFYIPISR-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-(2-methoxyethylamino)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.131; BCPWSYQGYBTINM-HDHZNLKHSA-N; [M+H]+; (3-hydroxy-1-methoxybutan-2-yl)imino-[(E)-oct-1-enyl]-oxidoazanium
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.076; YGIWHMMPMLSJEC-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-(3-aminopropoxy)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.025; FSBYQTNTIYRTQK-UHFFFAOYSA-N; [M+H]+; 2-[2-hydroxyethyl-[3-(8-oxa-6-azabicyclo[3.2.1]octan-6-yl)propyl]amino]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.002; COBARUFBUUGKQL-SNVBAGLBSA-N; [M+H]+; tert-butyl (4R)-4-(3-aminopropyl)-2,2-dimethyl-1,3-oxazolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.940; MNZPGBOZRFJAIS-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-(2-amino-3-hydroxypropyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.935; JIBIFMUBOQYMBV-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-(1-amino-2-hydroxypropan-2-yl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.930; XCRHXSARHPZOGG-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-methoxy-4-(methylaminomethyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.909; GXZMDYIRVQYTJY-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-amino-4-(2-methoxyethyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.906; WXMAGSGGBIUCBY-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-(4-hydroxybutyl)piperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.903; RISDUNPOTJNQHQ-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-(3-hydroxypropyl)-1,4-diazepane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.871; TWQINIJWWJMYFQ-NUHJPDEHSA-N; [M+H]+; (3S)-3-[[(2-amino-3-methylbutanoyl)amino]methyl]-5-methylhexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.780; JYYOCQRVLDWLAH-UHFFFAOYSA-N; [M+H]+; 4,5-dipentoxyimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.553; AGVKSBYAWLCYIW-UHFFFAOYSA-N; [M+H]+; ethyl 3-[dimethylamino(hexanoyl)amino]propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.537; VCOQSKBRYDHBAB-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-(2-aminoethoxy)-4-methylpiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -9.076; AJMOLNFDYWTVQW; [M+H]+; methyl 2-[(2-amino-4-methylpentanoyl)amino]-4-methylpentanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -77.508; CMQIGLGSRAQZAD; [M+H]+; Leucyl-leucine-methyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -149.307; AXIXBULJQSPZTL; [M+H]+; methyl N-[(3-methylbutyl)carbamoyl]isoleucinate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -300.071; WTSZPGPMXVFMCG; [M+H]+; 4-[2-(2-morpholin-4-ylethoxy)propyl]morpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -334.774; AGVKSBYAWLCYIW; [M+H]+; 3-(2,2-Dimethyl-1-hexanoylhydrazino)ethylpropionate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -391.497; ADEABMIOOCQJNK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -398.546; JYYOCQRVLDWLAH; [M+H]+; 4,5-dipentoxyimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -422.474; JYEJKYRGGNHIFS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -423.004; VVTOFDPELUVSDP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -429.282; BCPWSYQGYBTINM; [M+H]+; 2-Butanol, (E,Z)-(2S,3S)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -435.945; SYZRWJMIOVIOAQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -444.394; FSBYQTNTIYRTQK; [M+H]+; 6-(3-(Bis(2-hydroxyethyl)amino)propyl)-8-oxa-6-azabicyclo(3.2.1)octane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -448.900; MPCFXRWRKGJJPM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -452.634; MINKIWKBNNDDEK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -483.376; LKAKFPMASSTTNS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.881; AJMOLNFDYWTVQW; [M+H]+; methyl 2-[(2-amino-4-methylpentanoyl)amino]-4-methylpentanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -125.785; AJMOLNFDYWTVQW; [M+H]+; methyl 2-[[(2R)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -253.861; AXIXBULJQSPZTL; [M+H]+; methyl 3-methyl-2-{[(3-methylbutyl)carbamoyl]amino}pentanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -314.461; WTSZPGPMXVFMCG; [M+H]+; 4-(2-(1-Methyl-2-(4-morpholinyl)ethoxy)ethyl)morpholine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -316.265; CMQIGLGSRAQZAD; [M+H]+; 2-Amino-N-(1-methoxy-1-oxohexan-2-yl)hexanimidic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -354.366; DZQUGCQCUZQUBW; [M+H]+; tert-butyl N-[3-(piperidin-4-yloxy)propyl]carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -366.011; WXMAGSGGBIUCBY; [M+H]+; Tert-butyl 4-(4-hydroxybutyl)piperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -429.870; RISDUNPOTJNQHQ; [M+H]+; Tert-butyl 4-(3-hydroxypropyl)-1,4-diazepane-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -443.093; FSBYQTNTIYRTQK; [M+H]+; 6-(3-(Bis(2-hydroxyethyl)amino)propyl)-8-oxa-6-azabicyclo(3.2.1)octane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -464.301; JYYOCQRVLDWLAH; [M+H]+; 4,5-Bis(pentyloxy)-2-imidazolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -490.323; AGVKSBYAWLCYIW; [M+H]+; Hexanoic acid, 1-(3-ethoxy-3-oxopropyl)-2,2-dimethylhydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.962; AJMOLNFDYWTVQW; [M+H]+; methyl 2-[[(2R)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoate
COMMENT: CONFIDENCE Level 3: Tentative candidate, methyl (2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoate, AJMOLNFDYWTVQW-QWRGUYRKSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (3), MetFrag:MsfinderDB (8), MetFrag:PubchemLite (1);
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C13H26N2O3
CH$EXACT_MASS: 258.194343
CH$SMILES: CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)OC)N
CH$IUPAC: InChI=1S/C13H26N2O3/c1-8(2)6-10(14)12(16)15-11(7-9(3)4)13(17)18-5/h8-11H,6-7,14H2,1-5H3,(H,15,16)/t10-,11-/m0/s1
CH$NAME: Leucylleucine methyl ester
CH$NAME: methyl (2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoate
CH$LINK: INCHIKEY AJMOLNFDYWTVQW-QWRGUYRKSA-N
CH$LINK: PUBCHEM CID:7016877
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 µm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 2.869
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 259.201120
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-9000000000-6e1f801361f1b3701ca0
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  44.0493947 67.2922 44.049703 24.1093 38.72 0.6818 12 f{C2H6N1}/-1.84ppm,p-C11H21N1O3
  69.0699575 85.8169 69.070104 19.4296 44.44 0.6149 13 f{C5H9}/1.17ppm,p-C8H18N2O3
  86.0963332 999.0000 86.096549 12.4744 0.00 1.0000 17 f{C5H12N1}/-1.08ppm,p-C8H15N1O3
  146.1186821 118.1660 146.119247 17.9443 55.49 0.8679 16 f{C7H16N1O2}/7.71ppm,p-C6H11N1O1
PK$NUM_PEAK: 4
PK$PEAK: m/z int. rel.int.
  44.049395 67.29 67
  69.069957 85.82 85
  86.096333 999.00 999
  146.118682 118.17 118
//
